A detailed history of Simplex Trading, LLC transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 136 shares of HOWL stock, worth $285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136
Previous 202 32.67%
Holding current value
$285
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$2.34 - $6.75 $154 - $445
-66 Reduced 32.67%
136 $0
Q1 2024

Apr 25, 2024

SELL
$3.92 - $7.91 $21,544 - $43,473
-5,496 Reduced 96.45%
202 $1,000
Q4 2023

Feb 02, 2024

SELL
$1.78 - $4.15 $457 - $1,066
-257 Reduced 4.32%
5,698 $21,000
Q3 2023

Nov 01, 2023

BUY
$2.0 - $3.82 $10,652 - $20,345
5,326 Added 846.74%
5,955 $12,000
Q2 2023

Aug 04, 2023

BUY
$2.31 - $3.65 $1,452 - $2,295
629 New
629 $1,000

Others Institutions Holding HOWL

About Werewolf Therapeutics, Inc.


  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $62M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.